Prognia
Drug Database
🇪🇺EU · EMAAuthorisedATC: S01GX06

Emadine(emedastine difumarate)

Conjunctivitis, Allergic

Marketing Authorisation Holder: Immedica Pharma AB

EMA Authorisation: 27/01/1999

INN: emedastine

Indication

Symptomatic treatment of seasonal allergic conjunctivitis.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Emadine — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.